Ignite Creation Date:
2025-12-24 @ 4:12 PM
Ignite Modification Date:
2026-02-22 @ 5:09 PM
Study NCT ID:
NCT05024266
Status:
UNKNOWN
Last Update Posted:
2021-08-27
First Post:
2021-08-10
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Tislelizumab Combined With Chemotherapy as Neoadjuvant Therapy for Stage IIIA-IIIB (N2) Lung Squamous Cell Carcinoma
Sponsor:
First Affiliated Hospital of Zhejiang University
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
IIT20210011C-R1
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None